2009
DOI: 10.1016/s0065-2776(09)01204-8
|View full text |Cite
|
Sign up to set email alerts
|

Chapter 4 Micromanagers of Immune Cell Fate and Function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
9
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 97 publications
0
9
0
Order By: Relevance
“…The most common approaches are based on the hypothesis that genes sharing a similar temporal profile are regulated by common transcription factors (16). In mammals, a variety of post-transcriptional regulatory mechanisms can impact mRNA kinetics following up-regulation (17), so that requiring similarity across the entire time-series may be unnecessarily restrictive. As an alternative, we propose to focus on the initial up-regulation time as a criterion to identify genes that are likely to share common regulatory control logic.…”
Section: Introductionmentioning
confidence: 99%
“…The most common approaches are based on the hypothesis that genes sharing a similar temporal profile are regulated by common transcription factors (16). In mammals, a variety of post-transcriptional regulatory mechanisms can impact mRNA kinetics following up-regulation (17), so that requiring similarity across the entire time-series may be unnecessarily restrictive. As an alternative, we propose to focus on the initial up-regulation time as a criterion to identify genes that are likely to share common regulatory control logic.…”
Section: Introductionmentioning
confidence: 99%
“…13 Indeed, this unmet clinical need for the development of target specific cancer therapeutic agents have been emphasized by oncologists. Therefore, it is of paramount importance to develop novel drug delivery systems which provide superior capabilities for achieving optimal bioavailability of cytotoxic drugs at tumor sites while decreasing the systemic toxicity in tandem.…”
Section: Introductionmentioning
confidence: 99%
“…Compared to the studies on transactivation, the mechanisms involved in the negative regulation of IL-2 gene expression are less well studied. Although the roles of co-repressors and histone deacetylases in the transcriptional repression of IL-2 has been demonstrated [14], it is also becoming clear that a number of miRNAs are also involved in shaping of the immune responses [15,16] at least in part through the regulation of cytokine genes [17]. For example, miR-146a has been shown to modulate the adaptive immune responses by regulating the IL-2 expression in human T lymphocytes [18].…”
Section: Introductionmentioning
confidence: 99%